The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.20 (16.667%)
Open: 1.30
High: 1.30
Low: 1.30
Prev. Close: 1.30
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: G4S And Tullow Oil Lead FTSE 100 Gainers

Wed, 12th Nov 2014 12:02

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 WINNERS
-------
G4S, up 4.3%. The security company said organic revenue rose 4.2% in the first nine months of the year and it has agreed new contracts with annual revenues of over GBP870 million and total contract value of GBP1.7 billion. Contract retention for the nine months was similar to historical levels, at slightly above 90%, the company said.

Tullow Oil, up 1.5%. The oil explorer said it is reviewing its capital expenditure and costs, with overall exploration spending significantly reduced and focused primarily on East Africa where it has major basin-opening potential.
-------
FTSE 100 LOSERS
-------
Sainsbury's, down 5.4%. The supermarket operator swung to a pretax loss in the first half of the year, and outlined plans to cuts costs and capital expenditure. Pretax loss was GBP290 million for the 28 weeks to September 27 from a profit of GBP433 million in the same period a year earlier. First-half revenue fell 0.1% to GBP12.67 billion. It maintained its interim dividend, but its full-year dividend is expected to be cut.

Capita, down 5%. The outsourcing company said it has secured GBP1.63 billion of major sales so far this year, down from GBP2.9 billion in the same period last year when it had booked its largest ever contract worth GBP1.2 billion with O2.

SSE, down 2.7%. The utility reported a drop in pretax profit in the first half of the year due to warmer weather, lower electricity output and weak gas prices. For the six months ended September 30, pretax profit fell 6.2% to GBP316.6 million compared with GBP337.4 million a year earlier, mainly driven by a GBP22.1 million loss from its share of joint ventures.

Barclays, down 2%. The bank was among the five investigated by regulators over its FX dealings but remains in talks with regulators over its settlement. It has set aside GBP500 million in provisions to cover potential fines.

Burberry, down 1.2%. The luxury fashion retailer reported a 14% rise in underlying revenue of GBP1.1 billion but said it expects some pressure on full-year margin, a reflection of the strong pound, a more difficult external environment, and continued investments.

Royal Bank of Scotland, down 0.4%. The bank was one of five fined a total USD3.38 billion by UK, US and Swiss regulators for failings in its FX dealing operations. RBS was fined GBP399 million but said this is fully covered by provisions made in the third quarter.
-------
FTSE 250 WINNERS
-------
Essentra, up 2.5%. The company said it will buy the specialist packing arm of Clondalkin Group in a USD455 million deal, issuing shares to cover GBP160 million of the consideration. Clondalkin, which provides secondary packaging products for the pharmaceutical and healthcare industries, is owned by an affiliate of US private equity house Warburg Pincus and Essentra expects to complete the deal in the first quarter of 2015.

Moneysupermarket.com, up 2%. The price comparison website said it remains confident of meeting its expectations for the full year, after the "positive momentum and solid margins" seen in the third quarter continued through October. Third-quarter revenue rose by 18% year-on-year to GBP66.8 million, driven by increases in MoneySuperMarket.com, MoneySavingExpert.com, and TravelSupermarket.com, the company said
-------
FTSE 250 LOSERS
-------
SIG, down 7.5%. The building products distributor lowered its expectations for the year due to weak economic conditions in Europe, although it also raised its cost-benefit targets from the strategic initiatives it is taking.

Playtech, down 7.5%. Credit Suisse cut its rating on the stock to Underperform from Neutral and lowered its price target to 580 pence from 780p.

Diploma, down 1.6%. The company said Chairman John Rennocks is to step down from his role after the company's annual general meeting in January, appointing John Nicholas, currently a senior independent director on Diploma's board.
-------
AIM ALL-SHARE WINNERS
-------
Mountfield, up 8.1%. The company said its Connaught Access Flooring subsidiary has won a contract worth around GBP4.5 million to supply and install access flooring at a newly-built office development in the City of London. Work will start in January 2015 and is expected to be completed in the first quarter of 2016.

Solo Oil, up 7%. The company said it is awaiting formal approval from Tanzanian authorities for a deal that will see Solo buy a stake in the Kiliwani North Development license from Aminex, and the companies expect the deal to close shortly.
-------
AIM ALL-SHARE LOSERS
-------
Proteome Sciences, down 16%. The company said contract delays will mean its full-year revenue will come in below market expectations and lower than the revenue posted last year.

Quindell, down 9.6%. The company is understood to be on the brink of a formal probe by the City regulator over a share-transaction controversy which has caused its share price to plunge in the past week, the Daily Mail reported. The FCA declined to comment to Alliance News.

Physiomics, down 4%. The company posted a slightly narrowed loss in its year to end-June of GBP464,252, down from GBP543,791 a year before, as revenue rose to GBP267,903 from GBP240,000.
-------
By Ian Edmondson; ianedmondson@alliancenews.com;

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
2 Mar 2022 20:28

TRADING UPDATES: MediaZest virus hit; SpaceandPeople Network Rail deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
23 Feb 2022 14:48

IN BRIEF: Physiomics chair steps down after 15 years; CEO adds role

Physiomics PLC - oncology consultancy based in Oxford, England - Non-Executive Chair Paul Harper steps down from board immediately, having served on the board since 2004 and as chair since 2007. Chief Executive Officer Jim Millen will take on the additional role of executive chair. Physiomics also will recruit one independent non-executive director "as soon as possible".

Read more
21 Feb 2022 14:31

IN BRIEF: Physiomics shares up on continued DoseMeRx collaboration

Physiomics PLC - oncology consultancy based in Oxford - Confirms it will continue to collaborate with DoseMeRx, after Tabula Rasa Healthcare Inc announces it will sell DoseMeRx. The collaboration will explore further commercial opportunities in cancer field. Over 2021, Physiomics' personalised dosing application for docetaxel prostate cancer treatment was integrated into DoseMeRx platform, and was met with positive feedback.

Read more
22 Dec 2021 21:22

TRADING UPDATES: Mercia buys more Intechnica; Anexo scores VW win

TRADING UPDATES: Mercia buys more Intechnica; Anexo scores VW win

Read more
13 Dec 2021 20:22

IN BRIEF: Physiomics signs new deals with Merck worth GBP300,000

IN BRIEF: Physiomics signs new deals with Merck worth GBP300,000

Read more
13 Dec 2021 13:31

Physiomics signs £0.3m of new agreements with Merck

(Sharecast News) - Oncology consulting company Physiomics announced on Monday that it has signed new agreements with its existing client Merck with a total value of £0.3m.

Read more
16 Nov 2021 16:09

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
22 Oct 2021 13:06

IN BRIEF: Physiomics pens further deals with Merck KGaA

IN BRIEF: Physiomics pens further deals with Merck KGaA

Read more
22 Oct 2021 09:13

Physiomics awarded further contracts with Merck

(Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it had been awarded two further contracts by existing client Merck.

Read more
30 Sep 2021 15:45

EARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows

EARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows

Read more
23 Sep 2021 15:59

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
16 Sep 2021 20:36

IN BRIEF: Physiomics recruits first patient for Partner study

IN BRIEF: Physiomics recruits first patient for Partner study

Read more
21 May 2021 17:51

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

Read more
21 May 2021 11:48

AIM WINNERS & LOSERS: Arkle finds gold; Staffline raises cash

AIM WINNERS & LOSERS: Arkle finds gold; Staffline raises cash

Read more
21 May 2021 09:53

Physiomics inks further contracts with Bicycle Therapeutics

(Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it has been awarded two further contracts by existing client Bicycle Therapeutics.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.